Delivery Order SPE2DB25D3008-SPE2DB25FRDDH
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAMZARIC 28 MG-10 MG CAPSULE 30S, a prescription medication, with a ceiling value of $1,037.85. The contract has an ultimate completion date of November 22, 2023 and a pricing type of Firm Fixed Price. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,295.24, is for the delivery of Namenda XR 28 mg capsules in a 30-count supply. The contract has a period of performance through May 6, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the...
- The Defense Logistics Agency awarded a delivery order valued at $6,884.33 to AmerisourceBergen Drug Corp for the supply of Memantine HCl 2 mg/mL solution in 360 mL quantities. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- This federal contract award, valued at $2,173.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,561.84 and is for the delivery of Namenda 10 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at thirty-three thousand seven hundred dollars to supply sixty count bottles of the pharmaceutical memantine hydrochloride, a drug used to treat Alzheimer's disease. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. As a top supplier to the Department of Defense through contracts like the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) with a ceiling value of $11,028.36. This firm fixed-price delivery order, which is neither set-aside nor restricted, represents a competitively awarded procurement supporting federal medical supply needs. The work is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ingrezza 60 mg capsules (30-count packages) valued at $4,049.61. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...